Use of lip photoprotection in patients suffering from actinic cheilitis.

BACKGROUND: Actinic cheilitis (AC) is a chronic condition that affects mainly the lower lip. OBJECTIVES: To investigate the use of lip photoprotection in patients with AC. MATERIALS AND METHODS: A cross-sectional multicentre study of patients, ≥45 years of age, was performed in eight dermatology departments in the Galicia region over a period of one year. From 1,239 patients included in the study, 410 were diagnosed with AC and complete data were available for 408. An analysis of lip photoprotection habits and possible associations in patients with AC is reported. RESULTS: Mean age of patients with AC was 71.9 years and 53.8% were women. More than 90% of AC patients (370/408) had never used lip photoprotection. In the group of patients who used it, 62.16% of them had only used a single stick within the previous year. The only variable significantly associated with the use of lip sun protection was low Fitzpatrick's skin types I and II (p=0.039). Study limitations include the inclusion of patients 45 years or older and the use of a semiquantitative scale for measuring the frequency of application of lip photoprotection. CONCLUSION: To our knowledge, this is the first European study focused on lip photoprotection in patients suffering from AC. Only a minority of AC patients protect their lips from UV radiation. Specific lip sun protection recommendations should be promoted, especially in high-risk populations.

Actinic Cheilitis Prevalence and Risk Factors: A Cross-sectional, Multicentre Study in a Population Aged 45 Years and Over in North-west Spain.

Actinic cheilitis is thought to be a premalignant lesion or a superficial squamous cell carcinoma. The prevalence of actinic cheilitis in Europe is unknown. The aim of this study was to determine the prevalence of actinic cheilitis in the Galicia region (north-west Spain). Secondary objectives were the description of risk factors of actinic cheilitis. A cross-sectional multicentre study in patients ≥ 45 years of age was performed in 8 dermatology departments in Galicia region during a 1-year period. The prevalence of actinic cheilitis was 31.3%. Significant and independent risk factors of actinic cheilitis after multivariate analysis were age ≥ 60 years, Fitzpatrick skin phototype II, outdoor working for more than 25 years, and previous history of non-melanoma skin cancer. This is the first cross-sectional multicentre study of the prevalence of actinic cheilitis in Europe. Actinic cheilitis was present in almost one-third of the screened patients. Lip examination should be performed in all patients with chronic actinic damage.

Síndrome de Ehlers-Danlos, crioglobulinemia y dolor crónico / Ehlers-Danlos syndrome, cryoglobulinemia and chronic pain

Aportamos el caso de una paciente con síndrome de Ehlers-Danlos asociado a crioglobulinemia y dolor crónico musculoesquelético, con respuestaparcial a opioides. Ambas enfermedades pueden causar dolor crónico y su asociación llevar a confusión en el diagnóstico etiológico del dolor y a másdificultades en las opciones terapéuticas

A patient affected with Ehlers-Danlos syndrome associated with cryoglobulinemia, suffering from chronic musculoskeletal pain, with partial responseto opioids is reported. Both diseases may present with chronic pain and thus their association could lead to confusion in the etiologic diagnosis of painand to more difficulties in treatment options

Allergic contact dermatitis from EMLA cream in a hemodialyzed patient.

The eutectic mixture EMLA cream has many medical uses, including pain relief for hemodialyzed patients prior to cannulation. Cutaneous side effects associated with its application have rarely been reported. A patient on hemodialysis developed an itchy eruption over his brachial arteriovenous fistula, where he was applying EMLA cream three times per week, prior to puncture for hemodialysis. Patch testing elicited a positive reaction to several allergens, including EMLA cream "as is" and prilocaine. The lesions resolved after topical treatment with corticosteroids.

Hidroadenoma apocrino pigmentado / Pigmentes apocrine hidradenoma

El hidroadenoma apocrino es una neoplasia anexial benigna. No tiene predilección en cuanto a localización, y suele afectar a personas de edad media. Igual que en otros tumores de las glándulas sudoríparas, existe una variante pigmentada. Se presenta un caso de un varón de 92 años que consultó por una lesión asintomática en ingle derecha de crecimiento lento y 2 años de evolución. Tras el estudio histopatológico se estableció el diagnóstico de hidroadenoma apocrino pigmentado

Apocrine hidradenoma is a benign adnexal neoplasm. It has no specific site predilection, and usually affectsmiddle-aged people. The same as other tumors of the sweat glands, there is a pigmented variety. We present the case of a 92-year-old male who consulted hisphysician for a slow-growing asymptomatic lesion in the right groin which had been developing for 2 years. After the histopathologicalstudy, the diagnosis was established as pigmented apocrine hidradenoma

[Pigmented apocrine hidradenoma]. / Hidroadenoma apocrino pigmentado.

Apocrine hidradenoma is a benign adnexal neoplasm. It has no specific site predilection, and usually affects middle-aged people. The same as other tumors of the sweat glands, there is a pigmented variety. We present the case of a 92-year-old male who consulted his physician for a slow-growing asymptomatic lesion in the right groin which had been developing for 2 years. After the histopathological study, the diagnosis was established as pigmented apocrine hidradenoma.